功能性T细胞应答与治疗中断后HIV控制时间延长相关
该研究汇总六项HIV治愈试验中91名接受抗逆转录病毒治疗(ART)的感染者,分析治疗中断前HIV特异性T细胞应答与病毒反弹时间的关系。结果显示,治疗中断前较高的Gag特异性IFN-γ和CD8+ T细胞增殖应答与中断后第28天病毒学控制率更高及控制持续时间更长相关,支持CD8+ T细胞在维持病毒学控制中的作用。
要点
- 治疗中断前Gag特异性IFN-γ和CD8+ T细胞增殖应答高者,中断后病毒学控制时间更长。
- 上述应答与至首次血浆HIV RNA>50拷贝/mL的时间无关。
- 结果支持CD8+ T细胞在停止ART后维持病毒学控制中的作用。
核心结论
- 治疗中断前较高的Gag特异性IFN-γ和CD8+ T细胞增殖应答与停止ART后病毒学控制持续时间延长相关。
研究设计与样本
- 汇总六项HIV治愈试验数据,纳入91名接受ART(单用或联合潜伏逆转剂、TLR9激动剂或广谱中和抗体)的HIV感染者,治疗中断前采血行IFN-γ ELISpot和淋巴细胞增殖试验(LPA)。
主要发现
- 治疗中断后第28天有病毒学控制者(n=49)较无控制者治疗中断前Gag特异性IFN-γ应答更高(210 vs. 50 SFC/10^6 PBMCs,p=0.03),CD8+ T细胞增殖应答更高(0.48% vs. 0.16%,p=0.03)。
- Gag特异性IFN-γ应答高者与低者相比,病毒学控制中位持续时间分别为28天与21天(p<0.01);CD8+ T细胞增殖应答高者与低者相比分别为28天与21天(p=0.03)。
- ELISpot和LPA应答与至首次血浆HIV RNA>50拷贝/mL的时间无关。
临床怎么用
- 治疗中断前检测Gag特异性IFN-γ和CD8+ T细胞增殖应答可能有助于预判停止ART后病毒学控制持续时间。
- 上述指标与至首次HIV RNA>50拷贝/mL的时间无关,解读时应结合病毒学控制定义。
局限性
- 研究为汇总六项试验的事后分析,样本量有限(91人,90%男性,中位年龄45岁)。
- 原文未报告多变量校正结果,关联性不能等同于因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CD8+ T cell responses are thought to be critical for spontaneous control of human immunodeficiency virus (HIV) but findings supporting their role in post-intervention control have been mixed. We hypothesized that HIV-specific T cell proliferation, interferon-γ (IFN-γ) and granzyme B response prior to analytical treatment interruption (ATI) were associated with time to viral rebound. METHODS: We pooled data from six different HIV cure trials including people living with HIV receiving antiretroviral therapy (ART) alone or combined with latency reversing agents, Toll-Like receptor 9 agonists or broadly neutralizing antibodies. Pre-ATI blood samples were analysed by IFN-γ ELISpot and lymphocyte proliferation assay (LPA). RESULTS: We included 91 participants (90% male, median age 45 years). Compared to participants without virologic control (two consecutive measurements >1000 copies of HIV RNA/mL or ART restart), participants with virologic control at day 28 post-ATI (n=49) had higher Gag-specific IFN-γ (210 vs. 50 SFC/106 PBMCs, p=0.03) and CD8+ T cell proliferation (0.48% vs. 0.16%, p=0.03) responses pre-ATI. The median duration of virologic control was 28 vs. 21 days in people with high vs low Gag-specific IFN-γ response (p<0.01) or CD8+ T cell proliferation (p=0.03). ELISpot and LPA responses were not associated with time to first plasma HIV RNA of >50 copies/mL. CONCLUSIONS: These findings indicate that high pre-ATI Gag-specific IFN-γ and CD8+ T cell proliferation responses were associated with an increase in the duration of virological control after stopping ART, supporting a role for CD8+ T cells in sustaining virological control.
引用
- Andersen AB, Juhl AK, Gunst JD, et al. Functional T Cell Responses Are Associated With Prolonged HIV Control After Treatment Interruption. J Infect Dis. 2026. PMID: 42685288. doi:10.1093/infdis/jiag448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。